Rcm Technologies, INC 8-K filings

RCM Technologies, Inc. has dismissed EisnerAmper LLP as its independent auditor and engaged WithumSmith+Brown, PC, citing material weaknesses in internal controls.

RCM Technologies announced robust financial results for its fiscal year ended January 3, 2026, with significant increases in revenue, net income, and adjusted EBITDA.

RCM Technologies, Inc. and its subsidiaries have temporarily increased their revolving credit facility with Citizens Bank, N.A. from $65 million to $75 million until August 31, 2026.

RCM Technologies, Inc. stockholders approved a new 2025 Omnibus Equity Compensation Plan authorizing 1,000,000 shares and re-elected four directors at their annual meeting.

RCM Technologies announced increased revenue for Q3 2025 and year-to-date, alongside mixed profit metrics and strong forward-looking statements for Q4 and 2026.

RCM Technologies announced robust revenue growth and increased adjusted earnings per share for the second quarter and first half of 2025, driven by consistent performance across all segments.

RCM Technologies, Inc. has dismissed WithumSmith+Brown, PC and engaged EisnerAmper LLP as its new independent registered public accounting firm, effective June 30, 2025.

RCM Technologies approved grants of performance stock units to Michael Saks, the Division President of Health Care Services, based on operating income achievement.

RCM Technologies reports a significant increase in revenue and earnings for the first quarter of 2025, driven by strong operational performance and strategic investments.

RCM Technologies granted performance-based stock units to its Executive Chairman/President and CFO, contingent on EBITDA performance over a specified period.

RCM Technologies reports increased revenue for both the fourth quarter and fiscal year 2024, but experiences a decrease in net income and adjusted EBITDA compared to the previous year.

RCM Technologies held its 2024 annual meeting, electing four directors, ratifying its auditor, and approving executive compensation on an advisory basis.

RCM Technologies has entered into a Fifth Amended and Restated Loan Agreement, increasing its credit facility to $65 million with an option to expand by an additional $20 million.

RCM Technologies announced a 4.0% increase in revenue for the third quarter of 2024, driven by growth in its Healthcare and Engineering segments.

RCM Technologies announced a 3.2% increase in revenue for the second quarter of 2024, driven by growth in its engineering segment.

RCM Technologies has filed a legal opinion letter related to its previously announced at-the-market offering of up to $50 million in common stock.

RCM Technologies announced a 7.2% increase in revenue and a 7.1% increase in gross profit for the first quarter of 2024 compared to the same period last year.

RCM Technologies has corrected its name in its Articles of Incorporation, entered into an agreement for a potential $50 million at-the-market offering, and approved a $50 million share repurchase program.

RCM Technologies announced its fourth quarter and full fiscal year 2023 results, showing a strong fourth quarter but a decrease in full-year revenue.

RCM Technologies has granted a maximum of 50,000 performance stock units to its Executive Chairman and President, Bradley S. Vizi, based on EBITDA performance over a one-year period.

RCM Technologies has granted 250,000 performance stock units to its Executive Chairman, Bradley S. Vizi, with vesting contingent on achieving specific performance goals over four years.

RCM Technologies granted 2,668 restricted stock units to its Division President, Health Care Services, Michael Saks, valued at $80,000, vesting in five years.